Jan Janusz Sniatecki

Jan Janusz Sniatecki

Auto-generated profile, based on publicly available information

Jan Janusz Sniatecki

Department of Ophthalmology, University Medical Center, Johannes Gutenberg University Mainz, Langenbeckstr. 1, 55131 Mainz, Germany

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 2011 in American Journal of Physiology-Heart and Circulatory Physiology
Verified
Journal Article
Closed access
PDF file
Adrian GerickeAdrian Gericke
Adrian Gericke
JSJan J. Sniatecki
Jan J. Sniatecki
VMVeronique G. A. Mayer
Veronique G. A. Mayer
EGEvgeny Goloborodko
Evgeny Goloborodko
APAndreas Patzak
Andreas Patzak
NPNorbert Pfeiffer
Norbert Pfeiffer
Acetylcholine regulates perfusion of numerous organs via changes in local blood flow involving muscarinic receptor-induced release of vasorelaxing agents from the endothelium. The purpose of the present study was to determine the role of M1, M3, and M5muscarinic acetylcholine receptors in vasodilation of small arteries using gene-targeted mice deficient in either of the three receptor subtypes (M1R−/−, M3R−/−, or M5R−/−mice, respectively). Muscarinic receptor gene expression was determined in murine cutaneous, skeletal muscle, and renal interlobar arteries using real-time PCR. Moreover, respective arteries from M1R−/−, M3R−/−, M5R−/−, and wild-type mice were isolated, cannulated with micropipettes, and pressurized. Luminal diameter was measured using video microscopy. mRNA for all five muscarinic receptor subtypes was detected in all three vascular preparations from wild-type mice. However, M3receptor mRNA was found to be most abundant. Acetylcholine produced dose-dependent dilation in all three vascular preparations from M1R−/−, M5R−/−, and wild-type mice. In contrast, cholinergic dilation was virtually abolished in arteries from M3R−/−mice. Deletion of either M1, M3, or M5receptor genes did not affect responses to nonmuscarinic vasodilators, such as substance P and nitroprusside. These findings provide the first direct evidence that M3receptors mediate cholinergic vasodilation in cutaneous, skeletal muscle, and renal interlobar arteries. In contrast, neither M1nor M5receptors appear to be involved in cholinergic responses of the three vascular preparations tested.

1 September 2011 in Investigative Ophthalmology & Visual Science
Verified
Journal Article
Open access
PDF file
Adrian GerickeAdrian Gericke
Adrian Gericke
JSJan J. Sniatecki
Jan J. Sniatecki
EGEvgeny Goloborodko
Evgeny Goloborodko
ASAndreas Steege
Andreas Steege
OZOlga Zavaritskaya
Olga Zavaritskaya
NPNorbert Pfeiffer
Norbert Pfeiffer
Purpose.: To identify the muscarinic acetylcholine receptor subtype that mediates cholinergic vasodilation in murine retinal arterioles. Methods.: Muscarinic receptor gene expression was determined in murine retinal arterioles using real-time PCR. To assess the functional relevance of muscarinic receptors for mediating vascular responses, retinal vascular preparations from muscarinic receptor–deficient mice were studied in vitro. Changes in luminal arteriole diameter in response to muscarinic and nonmuscarinic vasoactive substances were measured by video microscopy. Results.: Only mRNA for the M3 receptor was detected in retinal arterioles. Thus, M3 receptor–deficient mice (M3R−/−) and respective wild-type controls were used for functional studies. Acetylcholine concentration-dependently dilated retinal arterioles from wild-type mice. In contrast, vasodilation to acetylcholine was almost completely abolished in retinal arterioles from M3R−/− mice, whereas responses to the nitric oxide (NO) donor nitroprusside were retained. Carbachol, an acetylcholinesterase-resistant analog of acetylcholine, also evoked dilation in retinal arterioles from wild-type, but not from M3R−/−, mice. Vasodilation responses from wild-type mice to acetylcholine were negligible after incubation with the non–subtype-selective muscarinic receptor blocker atropine or the NO synthase inhibitor Nω-nitro-l-arginine methyl ester, and were even reversed to contraction after endothelial damage with 3-[(3-cholamidopropyl)dimethylammonio]-1-propanesulfonate. Conclusions.: These findings provide evidence that endothelial M3 receptors mediate cholinergic vasodilation in murine retinal arterioles via activation of NO synthase.

1 April 2013 in Experimental Eye Research
Verified
Journal Article
Closed access
Adrian GerickeAdrian Gericke
Adrian Gericke
EGEvgeny Goloborodko
Evgeny Goloborodko
JSJan J. Sniatecki
Jan J. Sniatecki
ASAndreas Steege
Andreas Steege
LWLeszek Wojnowski
Leszek Wojnowski
NPNorbert Pfeiffer
Norbert Pfeiffer

1 October 2014 in Experimental Eye Research
Verified
Journal Article
Closed access
PLPanagiotis Laspas
Panagiotis Laspas
EGEvgeny Goloborodko
Evgeny Goloborodko
JSJan J. Sniatecki
Jan J. Sniatecki
MKMarcin L. Kordasz
Marcin L. Kordasz
CMCaroline Manicam
Caroline Manicam
Adrian GerickeAdrian Gericke
Adrian Gericke

9 December 2019 in European Journal of Ophthalmology
Verified
Journal Article
Closed access
PDF file
JSJan Janusz Sniatecki
Jan Janusz Sniatecki
GHGregory Ho-Yen
Gregory Ho-Yen
BCBenjamin Clarke
Benjamin Clarke
RBRamez Barbara
Ramez Barbara
SLStephen Lash
Stephen Lash
BGBhaskar Gupta
Bhaskar Gupta
Purpose: To evaluate visual and anatomic outcomes following pars plana vitrectomy and intravitreal or subretinal tissue plasminogen activator for submacular hemorrhage in patients with age-related macular degeneration. Methods: This was a retrospective study on patients with a minimum follow-up of 12 months undertaken at a tertiary referral center. Data collected include demographic details, visual and optical coherence tomography changes, surgical details, and complications. Surgical results were compared with patients who were age and lesion size matched and treated with anti-vascular endothelial growth factor injections alone. Results: There were 36 patients in surgical and 18 patients in control group. Patients in surgical arm had pars plana vitrectomy, intravitreal tissue plasminogen activator with air 24 (67%), 6 (16%) with C3F8 gas, 1 (3%) with SF6 gas, 4 (11%) subretinal tissue plasminogen activator with air, and 1 (3%) with C2F6 as post-operative tamponade. Mean LogMAR in tissue plasminogen activator group at baseline was 1.56, and it was improved at all time points 1.06 at 1 month (p < 0.05), 0.91 at 6 months (p < 0.05), and 1.07 at 1 year (p < 0.05). Mean best corrected visual acuity in control group at baseline was 1.22LogMAR with no significant improvement at any time points: 1 month (1.27), 6 months (1.35), and 12 months (1.36). Complications included retinal detachment 5%, vitreous hemorrhage 7.5%, and cataract 19%. Conclusion: Pars plana vitrectomy with intravitreal (or subretinal) tissue plasminogen activator and pneumatic displacement can offer better outcome in comparison to anti-vascular endothelial growth factor alone in patients with submacular hemorrhage secondary to age-related macular degeneration.

28 February 2015 in Journal of Molecular Neuroscience
Verified
Journal Article
Closed access
PDF file
PLPanagiotis Laspas
Panagiotis Laspas
JSJan J. Sniatecki
Jan J. Sniatecki
CBChristoph Brochhausen
Christoph Brochhausen
ASAndreas Steege
Andreas Steege
EGEvgeny Goloborodko
Evgeny Goloborodko
AGAdrian Gericke
Adrian Gericke